Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Depreciation and Depletion (2020 - 2024)

Dare Bioscience (DARE) has disclosed Depreciation and Depletion for 5 consecutive years, with $6368.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Depreciation and Depletion fell 36.19% year-over-year to $6368.0, compared with a TTM value of $42325.0 through Dec 2024, up 10.33%, and an annual FY2024 reading of $42325.0, up 10.33% over the prior year.
  • Depreciation and Depletion was $6368.0 for Q4 2024 at Dare Bioscience, down from $9742.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $15437.0 in Q2 2024 and bottomed at $3034.0 in Q3 2022.
  • Average Depreciation and Depletion over 5 years is $8726.5, with a median of $9384.0 recorded in 2023.
  • The sharpest move saw Depreciation and Depletion tumbled 52.17% in 2022, then surged 205.21% in 2023.
  • Year by year, Depreciation and Depletion stood at $6799.0 in 2020, then rose by 3.65% to $7047.0 in 2021, then skyrocketed by 50.73% to $10622.0 in 2022, then decreased by 6.04% to $9980.0 in 2023, then crashed by 36.19% to $6368.0 in 2024.
  • Business Quant data shows Depreciation and Depletion for DARE at $6368.0 in Q4 2024, $9742.0 in Q3 2024, and $15437.0 in Q2 2024.